Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vbeam Prima PDL and Rhofade for Erythematotelangiectatic Rosacea
NCT04153188Phase 4Completed
- Sponsor
- Candela Medical
- Start
- Jan 2019
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Candela Medical. Primary endpoint: Clinical Erythema Assessment Score. Started Jan 2019; status: completed.
Beyond the preview
Go deeper on NCT04153188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04153188.